BlueRock Therapeutics, created in 2016 (Canada), from 2081 sister brands and 17478 competing brands. The BlueRock Therapeutics brand is owned by BAYER, a company listed in Francfort. The ISIN, the company's International Securities Identification Number, is DE000BAY0017. The sector of BlueRock Therapeutics is Drug Manufacturers.

BlueRock Therapeutics is a brand of BAYER (BAYN) Share price

Date created : 2016 Business sector Drug Manufacturers

Share price and profitability of the share BAYER (BlueRock Therapeutics)

Buy BAYER share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 27.84

Portfolio valuation
BAYER (BlueRock Therapeutics) over 5 years* EUR 14.40

Stock market history BAYER (BlueRock Therapeutics)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
BAYER

Vividion Therapeutics
Vividion Therapeutics
Care/of
Care/of
Synpromics
Synpromics
RoverMed
RoverMed
BRAINVECTIS
BRAINVECTIS
ASKBIO
ASKBIO
See more brands of BAYER

Rival brands
BlueRock Therapeutics

Fusion Pharmaceuticals
Fusion Pharmaceuticals
POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS